Paul Tudor Jones’s Bioventus BVS Stock Holding History

Paul Tudor Jones’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$577K	Buy	+61,117	New	+$584K	﹤0.01%	2751
2026 Q1	–	Sell	-46,682	Closed	-$347K	–	3645
2025 Q4	$347K	Buy	+46,682	New	+$336K	﹤0.01%	2949
2025 Q3	–	Sell	-90,641	Closed	-$600K	–	3388
2025 Q2	$600K	Sell	90,641 -150,750	-62%	-$1.07M	﹤0.01%	2468
2025 Q1	$2.21M	Buy	241,391 +30,087	+14%	+$301K	0.01%	1284
2024 Q4	$2.22M	Sell	211,304 -45,830	-18%	-$542K	0.01%	1187
2024 Q3	$3.07M	Buy	257,134 +173,922	+209%	+$1.5M	0.01%	959
2024 Q2	$478K	Buy	+83,212	New	+$456K	﹤0.01%	1822
2022 Q3	–	Sell	-31,748	Closed	-$217K	–	2323
2022 Q2	$217K	Buy	31,748 +8,648	+37%	+$88.2K	0.01%	1765
2022 Q1	$326K	Sell	23,100 -48,939	-68%	-$655K	0.01%	1507
2021 Q4	$1.04M	Buy	+72,039	New	+$1.02M	0.02%	971
2021 Q2	–	Sell	-139,009	Closed	-$2.12M	–	1622
2021 Q1	$2.12M	Buy	+139,009	New	+$1.98M	0.04%	500

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paul Tudor Jones's BVS Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Bioventus (BVS) in Q2 2026: 61,117 shares worth $577K. The stake represents ﹤0.01% of the portfolio and ranks #2751 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in BVS as recently as Q4 2025.

Paul Tudor Jones first reported a position in BVS in Q1 2021 and has held it in 11 quarters since. The position peaked at $3.07M in Q3 2024. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

Paul Tudor Jones held 61,117 shares of Bioventus worth $577K as of Q2 2026.
Bioventus was a new Paul Tudor Jones position in Q2 2026.
Bioventus made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2751 holding.
Paul Tudor Jones first reported a position in Bioventus in Q1 2021 and has held it in 11 quarters since.
Paul Tudor Jones's Bioventus position peaked at $3.07M in Q3 2024.
156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.